|
On this page, you can select 「MainGroup」 or 「Facet」 in C07K. |
HB:Handbook | ||||
|
Select the desired 「MainGroup」 or 「facet」 etc. |
CC:Concordance | ||||
|
|
General processes for the preparation of peptides [4] | HB | CC | 4H045 | |
|
|
Peptides of undefined number of amino acids; Derivatives thereof [6] | HB | CC | 4H045 | |
|
|
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6] | HB | CC | 4H045 | |
|
|
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof [4] | HB | CC | 4H045 | |
|
|
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof [4,6] | HB | CC | 4H045 | |
|
|
Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof [4,6] | HB | CC | 4H045 | |
|
|
Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof [4,6] | HB | CC | 4H045 | |
|
|
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6] | HB | CC | 4H045 | |
|
|
Immunoglobulins, e.g. monoclonal or polyclonal antibodies [6] | HB | CC | 4H045 | |
|
|
Carrier-bound or immobilised peptides; Preparation thereof [4] | HB | CC | 4H045 | |
|
|
Hybrid peptides (hybrid immunoglobulins composedsolely of immunoglobulins C07K 16/46) [6] | HB | CC | 4H045 | |